Trastuzumab Plus Adjuvant Chemotherapy for Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Planned Joint Analysis of Overall Survival From NSABP B-31 and NCCTG N9831 Patients who are ...

Please provide your email address to receive an email when new articles are posted on . AGA guidance strongly recommends antiviral prophylaxis for patients at high risk for hepatitis B reactivation.

Finally, because the patient is a chronic carrier of HBV, the alpha-fetoprotein level should also be monitored every 6 months and an ultrasound examination of the liver performed annually to screen ...

Hepatitis B core antibody (HBcAb) is the first antibody to appear following acute hepatitis B infection and will persist in high levels following resolution of infection and in chronically infected ...

Stopping antiviral treatment in HBeAg-negative disease:- Further research should be undertaken to evaluate the clinical and cost effectiveness of hepatitis B surface antigen (HBsAg) quantitative ...

Background: The duration of protection after hepatitis B vaccination of infants is unknown. Methods: We determined antibody to hepatitis B surface antigen (anti-HBs) at 4-13 years of age in 363 low ...